<code id='067F328CA4'></code><style id='067F328CA4'></style>
    • <acronym id='067F328CA4'></acronym>
      <center id='067F328CA4'><center id='067F328CA4'><tfoot id='067F328CA4'></tfoot></center><abbr id='067F328CA4'><dir id='067F328CA4'><tfoot id='067F328CA4'></tfoot><noframes id='067F328CA4'>

    • <optgroup id='067F328CA4'><strike id='067F328CA4'><sup id='067F328CA4'></sup></strike><code id='067F328CA4'></code></optgroup>
        1. <b id='067F328CA4'><label id='067F328CA4'><select id='067F328CA4'><dt id='067F328CA4'><span id='067F328CA4'></span></dt></select></label></b><u id='067F328CA4'></u>
          <i id='067F328CA4'><strike id='067F328CA4'><tt id='067F328CA4'><pre id='067F328CA4'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:explore    Page View:66486

          A new Ebola epidemic in the Democratic Republic of the Congo is shaping up to be the most dangerous and difficult test of the world’s ability to contain the disease since the catastrophic West African outbreak in 2014 and 2015. What challenges are responders facing? And how might experimental vaccines be used to try to slow the spread of the epidemic?

          See below for an archived chat with Helen Branswell about these issues and more. 

          advertisement

          comprehensive

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          How neuroscience research could help beat back brain cancer
          How neuroscience research could help beat back brain cancer

          NewresearchledbyStanfordneuro-oncologistMichelleMonjeshineslightontheelectrochemicalsignalingpathway

          read more
          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more

          Sarepta Duchenne therapy fails to meet primary endpoint in trial

          RubyWallauforSTATSareptaTherapeuticssaidMondayafternoonthatitsgenetherapyforDuchennemusculardystroph